What Do My ARSACS MRI and EMG Test Results Mean?
At a Glance
ARSACS MRI results often show specific brain changes like pontine stripes, cerebellar vermis atrophy, and thalamic rims. EMG tests typically reveal sensorimotor polyneuropathy. Together, these diagnostic test results help neurologists confirm an ARSACS diagnosis and explain your symptoms.
In this answer
2 sections
Reading a diagnostic report can be incredibly stressful, especially when it is filled with dense medical jargon. If you are reviewing an MRI or EMG (electromyography) report for suspected or confirmed Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS), you might see complex terms describing changes in the brain or peripheral nerves. ARSACS is a slowly progressive condition, so these test results are simply a snapshot to help your medical team understand your specific baseline. Translating these terms into plain English can help you better understand your condition and feel more prepared to discuss the results with your neurologist.
Here is a breakdown of common terms you might see on your diagnostic reports and what they actually mean.
Understanding Your MRI Report
An MRI uses magnets to take detailed pictures of your brain. In ARSACS, doctors are typically looking for specific structural signs that help distinguish it from other conditions [1].
Pontine Stripes
You might see terms like “linear pontine hypointensities” or “pontine stripes”.
- What it means: The pons is a part of your brainstem that acts as a connection center for different areas of your brain. On a specific setting of the MRI machine (called a T2-weighted sequence), “hypointensities” appear as symmetric dark lines or stripes [2][3].
- Why it matters: These dark lines in the pons are a very classic and frequent hallmark of ARSACS [2][3]. Seeing these stripes helps radiologists differentiate ARSACS from other types of genetic ataxias [1]. However, it is important to know that milder or atypical cases might not have these stripes, and their absence does not automatically rule out ARSACS [4].
Cerebellar Vermis Atrophy
Your report may mention “atrophy of the superior and anterior cerebellar vermis.”
- What it means: The cerebellum is the part of your brain located at the back of your head, responsible for balance and coordination. The vermis is the central, worm-like part of the cerebellum. Atrophy refers to a loss of volume in this area over time [5][6].
- Why it matters: In ARSACS, specific cells in this balance center—called Purkinje cells—experience a gradual loss [5][6]. Because the cerebellum relies on these cells to function properly, this loss of volume leads to the unsteadiness and poor coordination (ataxia) that patients experience [7].
Thalamic Rims
You may also see references to “hyperintense rims around the thalami” or “bithalamic stripes.”
- What it means: The thalamus is a relay station deep in the brain. “Hyperintense rims” mean there is a bright outline around this area on the MRI [8].
- Why it matters: Alongside pontine stripes and loss of cerebellar volume, these bright rims are another characteristic puzzle piece that points toward an ARSACS diagnosis [8][2].
(Note on Spasticity: You might wonder where your muscle stiffness or “spasticity” comes from. Spasticity is generally caused by changes in the upper motor neurons and nerve pathways connecting the brain to the spinal cord. While your MRI might show signs like thinning of the spinal cord [1], the ataxia and neuropathy findings are often the most prominently described features on these specific reports).
Understanding Your EMG/Nerve Conduction Report
An EMG (electromyography) and nerve conduction study test how well and how fast electrical signals travel through your nerves to your muscles.
Sensorimotor Polyneuropathy (Demyelinating or Axonal)
Your report might state you have a “sensorimotor polyneuropathy” or describe it as “demyelinating” or “axonal.”
- What it means: Polyneuropathy means multiple peripheral nerves (the nerves outside your brain and spinal cord) are affected [9]. Sensorimotor means it involves both sensory nerves (which carry feelings like touch or temperature) and motor nerves (which control muscle movement) [9]. Demyelinating means the protective insulation around the nerve is affected, while Axonal means the core wire (axon) that carries the signal is impacted [10][11].
- Why it matters: While ARSACS nerve changes are classically described as primarily demyelinating [10], some patients experience primarily axonal changes, or a mix of both [11][4]. Regardless of the exact type listed on your report, this nerve involvement explains symptoms like muscle weakness, numbness, and changes in reflexes, typically starting in the lower legs and feet [12].
Diagnostic reports are highly technical documents written by doctors for other doctors. If your report contains other unfamiliar, intimidating words, try not to panic. The best approach is to highlight the terms you do not understand and review them directly with your neurologist.
Common questions in this guide
What do pontine stripes mean on an MRI?
Why does an ARSACS MRI report mention cerebellar vermis atrophy?
What does sensorimotor polyneuropathy mean on my EMG report?
Is ARSACS neuropathy primarily demyelinating or axonal?
Are pontine stripes always present in patients with ARSACS?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my MRI show the 'classic' features of ARSACS like pontine stripes, or is my presentation more atypical?
- 2.Based on my EMG results, is my neuropathy primarily demyelinating or axonal, and does that change how we manage my symptoms?
- 3.Are there baseline imaging or nerve conduction studies we should repeat in the future to track the progression of my condition?
- 4.I didn't see an OCT (Optical Coherence Tomography) scan of my eyes ordered; is that a test we should consider to look for retinal nerve thickening?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
MRI-ARSACS: An Imaging Index for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) Identification Based on the Multicenter PROSPAX Study.
Scaravilli A, Negroni D, Senatore C, et al.
Movement disorders : official journal of the Movement Disorder Society 2024; (39(8)):1343-1351 doi:10.1002/mds.29871.
PMID: 38847051 - 2
Clinical and Molecular Findings of Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay: an Iranian Case Series Expanding the Genetic and Neuroimaging Spectra.
Ashrafi MR, Mohammadi P, Tavasoli AR, et al.
Cerebellum (London, England) 2023; (22(4)):640-650 doi:10.1007/s12311-022-01430-3.
PMID: 35731353 - 3
Clinical, ophthalmological, imaging and genetic features in Brazilian patients with ARSACS.
Rezende Filho FM, Parkinson MH, Pedroso JL, et al.
Parkinsonism & related disorders 2019; (62()):148-155 doi:10.1016/j.parkreldis.2018.12.024.
PMID: 30638817 - 4
SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy.
Vill K, Müller-Felber W, Gläser D, et al.
Human genetics 2018; (137(11-12)):911-919 doi:10.1007/s00439-018-1952-6.
PMID: 30460542 - 5
ARSACS: Clinical Features, Pathophysiology and iPS-Derived Models.
Salem IH, Blais M, Zuluaga-Sánchez VM, et al.
Cerebellum (London, England) 2025; (24(1)):24 doi:10.1007/s12311-024-01777-9.
PMID: 39753868 - 6
Alterations in the Na+/H+ Exchanger NHE6 and Glutamate Transporters may Influence Purkinje Cell Fate in ARSACS.
Masson LC, Kanagasabai AS, Márquez BT, et al.
Cerebellum (London, England) 2025; (24(4)):99 doi:10.1007/s12311-025-01850-x.
PMID: 40372562 - 7
Consensus Paper: Ataxic Gait.
Cabaraux P, Agrawal SK, Cai H, et al.
Cerebellum (London, England) 2023; (22(3)):394-430 doi:10.1007/s12311-022-01373-9.
PMID: 35414041 - 8
ARSACS as a Worldwide Disease: Novel SACS Mutations Identified in a Consanguineous Family from the Remote Tribal Jammu and Kashmir Region in India.
Kuchay RAH, Mir YR, Zeng X, et al.
Cerebellum (London, England) 2019; (18(4)):807-812 doi:10.1007/s12311-019-01028-2.
PMID: 30963395 - 9
Teaching NeuroImages: Autosomal recessive spastic ataxia of Charlevoix-Saguenay: Typical MRI findings.
Biswas A, Varman M, Yoganathan S, et al.
Neurology 2018; (90(14)):e1271-e1272 doi:10.1212/WNL.0000000000005252.
PMID: 29610238 - 10
Neuropathy in ARSACS is demyelinating but without typical nerve enlargement in nerve ultrasound.
Kneer K, Straub S, Wittlinger J, et al.
Journal of neurology 2024; (271(5)):2494-2502 doi:10.1007/s00415-023-12159-2.
PMID: 38261029 - 11
Early-onset axonal Charcot-Marie-Tooth disease due to SACS mutation.
Souza PVS, Bortholin T, Naylor FGM, et al.
Neuromuscular disorders : NMD 2018; (28(2)):169-172 doi:10.1016/j.nmd.2017.11.008.
PMID: 29277257 - 12
A novel hemizygous SACS mutation identified by whole exome sequencing and SNP array analysis in a Chinese ARSACS patient.
Liu L, Li XB, Zi XH, et al.
Journal of the neurological sciences 2016; (362()):111-4.
PMID: 26944128
This page explains ARSACS MRI and EMG diagnostic terminology for educational purposes. Always consult your neurologist for the interpretation of your specific reports.
Get notified when new evidence is published on Autosomal recessive spastic ataxia of Charlevoix-Saguenay.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.